Related Experiment Video
Updated: Feb 15, 2026

Evaluation of Right Ventricular Function in Experimental Models of Pulmonary Arterial Hypertension
Published on: June 27, 2025
BIOMARKERS OF CARDIOMETABOLIC RISK IN PATIENTS WITH ARTERIAL HYPERTENSION: A CROSS-SECTIONAL PILOT STUDY
G Derbissalina1, Z Bekbergenova1, A Umbetzhanova1
11NJSC "Astana Medical University", Astana, Republic of Kazakhstan.
Insights
Cardiometabolic biomarkers like waist circumference, BMI, and LDL-C are linked to cardiovascular disease in hypertensive patients in Kazakhstan. Further research is needed to understand region-specific risk factors.
Area of Science:
- Cardiology
- Endocrinology
- Public Health
Background:
- Arterial hypertension is a major risk factor for cardiovascular disease.
- Cardiometabolic biomarkers play a crucial role in assessing cardiovascular risk.
- Understanding regional variations in cardiometabolic risk is essential for targeted interventions.
Purpose of the Study:
- To comprehensively assess cardiometabolic biomarkers in patients with arterial hypertension.
- To analyze the relationship between these biomarkers and coronary artery disease (CAD) and atherosclerosis.
- To identify potential region-specific cardiometabolic risk patterns in Kazakhstan.
Main Methods:
- A pilot study involving 31 patients with established arterial hypertension.
- Assessment of anthropometric indicators (waist circumference, BMI), lipid parameters (LDL-C, total cholesterol, triglycerides), and systolic blood pressure.
- Evaluation of biomarker associations with documented coronary artery disease and atherosclerosis.
Main Results:
- Strongest associations with CAD and atherosclerosis were found for waist circumference, BMI, LDL-C, total cholesterol, triglycerides, and systolic blood pressure.
- Elevated lipoprotein(a) levels were observed in some patients without confirmed disease, suggesting potential subclinical vascular involvement.
- Findings align with previously described cardiometabolic patterns in the Kazakhstani population.
Conclusions:
- Comprehensive assessment of anthropometric and biochemical biomarkers aids in early cardiovascular risk stratification for hypertensive patients in Kazakhstan.
- Observed trends suggest potential region-specific features of cardiometabolic risk.
- Further investigation in larger cohorts is warranted to confirm these region-specific findings.
Aim Of The Study:
To provide a comprehensive assessment of cardiometabolic biomarkers in patients with arterial hypertension and to analyze their relationship with the presence of coronary artery disease and atherosclerosis, as well as to outline directions for further research.
Materials And Methods:
A pilot sample of 31 patients with established arterial hypertension was analyzed. Anthropometric indicators, lipid parameters, and inflammatory biomarkers were assessed in relation to documented coronary artery disease and atherosclerosis.
Results:
The strongest associations with coronary artery disease and atherosclerosis were observed for waist circumference, BMI, LDL-C, total cholesterol, triglycerides, and systolic blood pressure. Elevated lipoprotein(a) levels were noted in several patients without confirmed disease, suggesting possible early subclinical vascular involvement. These trends are consistent with previously described cardiometabolic patterns in the Kazakhstani population.
Conclusion:
Comprehensive assessment of anthropometric and biochemical biomarkers may be useful for early cardiovascular risk stratification in patients with arterial hypertension in Kazakhstan. The observed tendencies highlight potential region-specific features of cardiometabolic risk, warranting further investigation in larger cohorts.
Related Concept Videos
Cross-Sectional Research
Finding Volume Using Cross-Sectional Area
Profile Leveling and Cross Sections
Spinal Cord: Cross-sectional Anatomy
Gray Matter and its Components
Central to the gray matter is...
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...

